MATAURO’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

MATAURO’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$215K	Buy	+7,417	New	+$215K	0.03%	130
2025 Q4	–	Sell	-11,067	Closed	-$261K	–	163
2025 Q3	$261K	Buy	11,067 +1,097	+11%	+$24.3K	0.04%	124
2025 Q2	$204K	Buy	9,970 +73	+0.7%	+$1.47K	0.04%	129
2025 Q1	$203K	Hold	9,897	–	–	0.04%	116
2024 Q4	$224K	Buy	+9,897	New	+$238K	0.05%	105

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

MATAURO's IDNA Position: Q1 2026 in Review

MATAURO opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2026: 7,417 shares worth $215K. The stake represents 0.03% of the portfolio and ranks #130 among its holdings. This is a return to the name: MATAURO previously reported a position in IDNA as recently as Q3 2025.

MATAURO first reported a position in IDNA in Q4 2024 and has held it in 5 quarters since. The position peaked at $261K in Q3 2025. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

MATAURO held 7,417 shares of iShares Genomics Immunology and Healthcare ETF worth $215K as of Q1 2026.
iShares Genomics Immunology and Healthcare ETF was a new MATAURO position in Q1 2026.
iShares Genomics Immunology and Healthcare ETF made up 0.03% of MATAURO's portfolio in Q1 2026, its #130 holding.
MATAURO first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2024 and has held it in 5 quarters since.
MATAURO's iShares Genomics Immunology and Healthcare ETF position peaked at $261K in Q3 2025.
60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on MATAURO's 13F filing for Q1 2026, filed 22 Apr 2026.